Blockade of endothelin receptors in cardiovascular diseases. a possible therapeutic alternative in the future
Pernow, J.; Lundberg, J.M.
Lakartidningen 94(12): 1069-1073
1997
ISSN/ISBN: 0023-7205 PMID: 9121239 Document Number: 471031
Document emailed within 1 workday
Related Documents
Berthiaume, N.; Yanagisawa, M.; D'Orléans-Juste, P. 2000: Contribution of endogenous endothelin-1 and endothelin-A-receptors to the hypertensive state of endothelin-B heterozygous (+/-) knockout mice Journal of Cardiovascular Pharmacology 36(5 Suppl 1: S72-S74Dobrek, Łu.; Thor, P. 2010: Endothelin in cardiovascular diseases pathophysiology Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 28(166): 289-292
Sternitzke, N.; Schieffer, H.; Hoffmann, W.; Bette, L. 1976: Modification of the cardiovascular-dynamic effect of Akrinor following the blockade of adrenergic beta receptors with propranolol Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1132-1135
Juan, C.C.; Fang, V.S.; Hsu, Y.P.; Huang, Y.J.; Hsia, D.B.; Yu, P.C.; Kwok, C.F.; Ho, L.T. 1998: Overexpression of vascular endothelin-1 and endothelin-A receptors in a fructose-induced hypertensive rat model Journal of Hypertension 16(12 Pt 1): 1775-1782
Kobayashi, T.; Miyauchi, T.; Sakai, S.; Kobayashi, M.; Yamaguchi, I.; Goto, K.; Sugishita, Y. 1999: Expression of endothelin-1, ETA and ETB receptors, and ECE and distribution of endothelin-1 in failing rat heart American Journal of Physiology 276(4): H1197-H1206
Ryvkin, I.A. 1971: Mortality of the population from the most important cardiovascular diseases and possible changes in future years Kardiologiia 11(9): 47-53
Rämö, O.J.; Rämö, M.P.; Mokka, R.E.; Mattila, S. 1993: Angioscopy--future method in diagnosis and treatment of cardiovascular diseases Duodecim; Laaketieteellinen Aikakauskirja 109(19): 1661-1666
Jero, J.; Aarnisalo, A. 2011: Future therapeutic options for inner ear diseases Duodecim; Laaketieteellinen Aikakauskirja 127(8): 848-853
Klitgaard, T.Lykke.S.; Haamann, P.H.; Villumsen, Jørgen.E.; Larsen, M. 2005: Intravitreal triamcinolone therapy. New therapeutic alternative for patients with vision-threatening eye diseases Ugeskrift for Laeger 167(16): 1729-1731
Geissler, W. 1974: Use of activating therapeutic technics in cardiovascular diseases Zeitschrift für die Gesamte Hygiene und ihre Grenzgebiete 20(6): 347-348
Roĭtman, M.P.; Lunskaia, L.L. 1982: Economic effectiveness of prophylactic and therapeutic measures in cardiovascular diseases Sovetskoe Zdravookhranenie 5: 50-54
Purcell, H. 1994: Present and future possibilities in the use of calcium antagonists in the therapy of cardiovascular diseases with special emphasis on amlodipine Vnitrni Lekarstvi 40(8): 545
Moreau, P.; Takase, H.; Küng, C.F.; Shaw, S.; Lüscher, T.F. 1997: Blood pressure and vascular effects of endothelin blockade in chronic nitric oxide-deficient hypertension Hypertension 29(3): 763-769
Casteilla, L.; Planat-Bénard, V.; Cousin, B.; Silvestre, J.S.; Laharrague, P.; Charrière, G.; Carrière, A.; Pénicaud, L. 2005: Plasticity of adipose tissue: a promising therapeutic avenue in the treatment of cardiovascular and blood diseases? Archives des Maladies du Coeur et des Vaisseaux 98(9): 922-926
Obrosov, A.N. 1970: Main mechanisms of therapeutic action of health resort and physiotherapeutic factors in cardiovascular diseases Vestnik Akademii Meditsinskikh Nauk SSSR 25(4): 79-85
Pons, J.; Lee, E.W.; Li, L.; Kitlinska, J. 2004: Neuropeptide Y: multiple receptors and multiple roles in cardiovascular diseases Current Opinion in Investigational Drugs 5(9): 957-962
Weser, C.; Klessen, D. 1978: Strategy for the control of cardiovascular diseases in a metropolis (demonstrated by the Berlin concept of a unified system of care for patients with cardiovascular diseases) Zeitschrift für Arztliche Fortbildung 72(20): 967-971
Floru, L.; Tegeler, J. 1974: Therapeutic significance of the beta-receptor blockade in lithium-induced tremor. Therapeutic trials with Pindolol and Practolol Die Medizinische Welt 25(11): 450
Aly, D.G.; Salem, S.A.M.; Abdel-Hamid, M.F.; Youssef, N.S.; El Shaer, M.A.M. 2013: Endothelin-1 and its a and B receptors: are they possibly involved in vitiligo? Acta Dermatovenerologica Croatica: Adc 21(1): 12-18
Sahach, V.F. 1998: Endothelin and the cardiovascular system Fiziolohichnyi Zhurnal 44(1-2): 103-111